Serum Bilirubin and Risk of Respiratory Disease and Death

Feb-11

AUTHORS : Dr Laura Horsfall, Research Department of Primary care and Population Health, Upper Third Floor, UCL Medical School (Royal Free Campus), Rowland Hill Street, London NW3 2PF – Email: laura.horsfall@ucl.ac.uk – Profile: https://iris.ucl.ac.uk/iris/browse/profile?upi=LJHOR45

JOURNAL : JAMA

REFERENCE: 305(7): 691-697

DOI : 10.1001/jama.2011.124

Serum Bilirubin and Risk of Respiratory Disease and Death

More publications

COPD Exacerbations Before and During COVID-19 in France, Germany, Italy, the UK and the US

Duration of Invasive Mechanical Ventilation before Veno-Venous ExtraCorporeal Membrane Oxygenation for Covid-19 related Acute Respiratory Distress Syndrome: The experience of a tertiary care center

Use and persistence of single and multiple inhaler triple therapy prescribed for patients with COPD in France: a retrospective study on THIN database (OPTI study)